Detalhe da pesquisa
1.
Efficacy and safety of baricitinib in combination with topical corticosteroids in paediatric patients with moderate-to-severe atopic dermatitis with an inadequate response to topical corticosteroids: results from a phase III, randomized, double-blind, placebo-controlled study (BREEZE-AD PEDS).
Br J Dermatol
; 189(1): 23-32, 2023 07 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36999560
2.
Acroosteolysis and bone metabolism parameters distinguish female patients with limited systemic sclerosis with and without calcinosis: a case control study.
Clin Rheumatol
; 38(11): 3189-3193, 2019 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-31218481